Cargando…

When to start antiretroviral therapy: the need for an evidence base during early HIV infection

BACKGROUND: Strategies for use of antiretroviral therapy (ART) have traditionally focused on providing treatment to persons who stand to benefit immediately from initiating the therapy. There is global consensus that any HIV+ person with CD4 counts less than 350 cells/μl should initiate ART. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lundgren, Jens D, Babiker, Abdel G, Gordin, Fred M, Borges, Álvaro H, Neaton, James D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682886/ https://www.ncbi.nlm.nih.gov/pubmed/23767777 http://dx.doi.org/10.1186/1741-7015-11-148

Ejemplares similares

When to start antiretroviral therapy: as soon as possible
por: Franco, Ricardo A, et al.
Publicado: (2013)

When Should Children with HIV Infection Be Started on Antiretroviral Therapy?
por: Welch, Steven B, et al.
Publicado: (2008)

When to start antiretroviral therapy in resource-limited settings: a human rights analysis
por: Ford, Nathan, et al.
Publicado: (2010)

LB2305. Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial
por: Babiker, Abdel G, et al.
Publicado: (2022)

A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings
por: Osler, Meg, et al.
Publicado: (2014)

How to proceed when evidence-based practice is required but very little evidence available?
por: Leboeuf-Yde, Charlotte, et al.
Publicado: (2013)

Health economics: the start of clinical freedom
por: Sacristán, José Antonio, et al.
Publicado: (2010)

Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA
por: Deblonde, Jessika, et al.
Publicado: (2015)

HIV prevention, structural change and social values: the need for an explicit normative approach
por: Parkhurst, Justin O
Publicado: (2012)

Designing theoretically-informed implementation interventions: Fine in theory, but evidence of effectiveness in practice is needed
por: Bhattacharyya, Onil, et al.
Publicado: (2006)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Comments on the need for a new look at public policies on food and nutrition in early childhood
por: Bortolini, Gisele Ane
Publicado: (2023)

When should antiretroviral therapy be started in HIV-positive persons?
por: Sabin, Caroline A
Publicado: (2010)

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?
por: Franco-Paredes, Carlos, et al.
Publicado: (2017)

Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs
por: Amon, Joseph J
Publicado: (2008)

Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy
por: McLaren, Zoë M., et al.
Publicado: (2016)

Need to Knowledge (NtK) Model: an evidence-based framework for generating technological innovations with socio-economic impacts
por: Flagg, Jennifer L, et al.
Publicado: (2013)

What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion
por: Dukers-Muijrers, Nicole H. T. M., et al.
Publicado: (2015)

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial
por: Baker, Jason V, et al.
Publicado: (2017)

Sexual and reproductive health self-care in humanitarian and fragile settings: where should we start?
por: Tran, Nguyen Toan, et al.
Publicado: (2021)

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
por: Dharan, Nila J., et al.
Publicado: (2019)

What counts as reliable evidence for public health policy: the case of circumcision for preventing HIV infection
por: Lie, Reidar K, et al.
Publicado: (2011)

What is presumed when we presume consent?
por: Pierscionek, Barbara K
Publicado: (2008)

Better governance starts with better words: why responsible human tissue research demands a change of language
por: Lensink, Michael A., et al.
Publicado: (2022)

Why Australia needs to define obesity as a chronic condition
por: Opie, C. A., et al.
Publicado: (2017)

Implications of prioritizing HIV cure: new momentum to overcome old challenges in HIV
por: Tucker, Joseph D., et al.
Publicado: (2016)

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial
por: Baker, Jason V., et al.
Publicado: (2017)

Untying the Gordian knot: remediation problems in medical schools that need remediation
por: Bennion, Layne D., et al.
Publicado: (2018)

Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
por: Munn, Zachary, et al.
Publicado: (2018)

1284. Study of Single Nucleotide Polymorphisms Associated with HIV-1 Set-Point Viral Load in Antiretroviral Therapy-Naïve HIV-Positive Participants of the START Study
por: Ekenberg, Christina, et al.
Publicado: (2018)

Sports-based recreation as a means to address social inequity in health: why, when, where, who, what, and how
por: Elsborg, Peter, et al.
Publicado: (2019)

Integration of HIV care into maternal health services: a crucial change required in improving quality of obstetric care in countries with high HIV prevalence
por: Madzimbamuto, Farai D, et al.
Publicado: (2013)

Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection
por: Gilbertson, Adam, et al.
Publicado: (2021)

The ethics of talking about ‘HIV cure’
por: Rennie, Stuart, et al.
Publicado: (2015)

Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health
por: D'Hooghe, Thomas
Publicado: (2017)

When to start: not so fast
por: Lundgren, J
Publicado: (2012)

When is good, good enough? Methodological pragmatism for sustainable guideline development
por: Browman, George P, et al.
Publicado: (2015)

Temporary services for patients in need of chronic care
por: Hesse, Morten
Publicado: (2008)

Why do you need a biostatistician?
por: Zapf, Antonia, et al.
Publicado: (2020)

Is it time to shift the attention on early stages embryo development to avoid inconclusive evidence on HPV-related infertility: debate and proposal
por: Noventa, Marco, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oie8ko2mdc21robmc67bl2ruhg